University of New Mexico Health Sciences Center, Albuquerque, NM 87131-5271, USA.
J Am Soc Nephrol. 2010 Nov;21(11):1970-8. doi: 10.1681/ASN.2010010125. Epub 2010 Oct 14.
Observational studies involving hemodialysis patients suggest a U-shaped relationship between BP and mortality, but the majority of these studies followed large, heterogeneous cohorts. To examine whether age, race, and diabetes status affect the association between systolic BP (SBP; predialysis) and mortality, we studied a cohort of 16,283 incident hemodialysis patients. We constructed a series of multivariate proportional hazards models, adding age and BP to the analyses as cubic polynomial splines to model potential nonlinear relationships with mortality. Overall, low SBP associated with increased mortality, and the association was more pronounced among older patients and those with diabetes. Higher SBP associated with increased mortality among younger patients, regardless of race or diabetes status. We observed a survival advantage for black patients primarily among older patients. Diabetes associated with increased mortality mainly among older patients with low BP. In conclusion, the design of randomized clinical trials to identify optimal BP targets for patients with ESRD should take age and diabetes status into consideration.
观察性研究表明,血液透析患者的血压(BP)与死亡率之间呈 U 型关系,但这些研究大多是对大型、异质队列进行的。为了研究年龄、种族和糖尿病状态是否影响收缩压(SBP;透析前)与死亡率之间的关系,我们研究了 16283 名新进入血液透析的患者队列。我们构建了一系列多变量比例风险模型,将年龄和 BP 作为三次多项式样条添加到分析中,以对与死亡率的潜在非线性关系进行建模。总的来说,SBP 较低与死亡率增加相关,且这种关联在年龄较大的患者和患有糖尿病的患者中更为明显。而在年轻患者中,较高的 SBP 与死亡率增加相关,无论其种族或糖尿病状态如何。我们观察到黑人患者的生存优势主要出现在年龄较大的患者中。糖尿病与死亡率增加相关,主要发生在血压较低的老年患者中。总之,为终末期肾脏疾病患者确定最佳血压目标的随机临床试验设计应考虑年龄和糖尿病状态。